Literature DB >> 24156336

Potential role of Anxa1 in cancer.

Chunmei Guo1, Shuqing Liu, Ming-Zhong Sun.   

Abstract

The annexins are a well-known, closely related, multigene superfamily of Ca(2+)-regulated, phospholipid-dependent, membrane-binding proteins. As a member of the annexins, Anxa1 participates in a variety of important biological processes, such as cellular transduction, membrane aggregation, inflammation, phagocytosis, proliferation, differentiation and apoptosis. Accumulated evidence has indicated that Anxa1 deregulations are associated with the development, invasion, metastasis, occurrence and drug resistance of cancers. The research evidence in recent years indicates that Anxa1 might specifically function either as a tumor suppressor or a tumor promoter candidate for certain cancers depending on the particular type of tumor cells/tissues. This article summarizes the associations between Anxa1 and malignant tumors, as well as potential action mechanisms. Anxa1 has the potential to be used in the future as a biomarker for the diagnosis, treatment and prognosis of certain tumors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24156336     DOI: 10.2217/fon.13.114

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  55 in total

1.  Prioritizing predictive biomarkers for gene essentiality in cancer cells with mRNA expression data and DNA copy number profile.

Authors:  Yuanfang Guan; Tingyang Li; Hongjiu Zhang; Fan Zhu; Gilbert S Omenn
Journal:  Bioinformatics       Date:  2018-12-01       Impact factor: 6.937

2.  Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1.

Authors:  Mara Roxana Rubinstein; Jung Eun Baik; Stephen M Lagana; Richard P Han; William J Raab; Debashis Sahoo; Piero Dalerba; Timothy C Wang; Yiping W Han
Journal:  EMBO Rep       Date:  2019-03-04       Impact factor: 8.807

3.  ANXA1 affects cell proliferation, invasion and epithelial-mesenchymal transition of oral squamous cell carcinoma.

Authors:  Ying-Ming Wan; Jing Tian; Ling Qi; Li-Mei Liu; Ning Xu
Journal:  Exp Ther Med       Date:  2017-09-20       Impact factor: 2.447

4.  Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer.

Authors:  Chao-Chi Yeh; Chih-Hung Hsu; Yu-Yun Shao; Wen-Ching Ho; Mong-Hsun Tsai; Wen-Chi Feng; Lu-Ping Chow
Journal:  Mol Cell Proteomics       Date:  2015-04-07       Impact factor: 5.911

5.  Annexin A2 is an independent prognostic biomarker for evaluating the malignant progression of laryngeal cancer.

Authors:  Shi Luo; Chubo Xie; Ping Wu; Jian He; Yaoyun Tang; Jing Xu; Suping Zhao
Journal:  Exp Ther Med       Date:  2017-10-12       Impact factor: 2.447

6.  Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer.

Authors:  Shuliang Yu; Qian Meng; Huihui Hu; Man Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

7.  Downregulation of Annexin A1 is correlated with radioresistance in nasopharyngeal carcinoma.

Authors:  Lifang Huang; Li Liao; Yanping Wan; Ailan Cheng; Meixiang Li; Sihan Chen; Maoyu Li; Xing Tan; Guqing Zeng
Journal:  Oncol Lett       Date:  2016-10-27       Impact factor: 2.967

8.  Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma.

Authors:  Gaohua Han; Ye Tian; Bensong Duan; Haihui Sheng; Hengjun Gao; Junxing Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

9.  Upregulation of annexin A1 expression by butyrate in human melanoma cells induces invasion by inhibiting E-cadherin expression.

Authors:  Jimin Shin; In-Sung Song; Jhang Ho Pak; Sung-Wuk Jang
Journal:  Tumour Biol       Date:  2016-09-10

10.  Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer.

Authors:  Raoudha Doghri; Pascal Finetti; Karima Mrad; Maroua Manai; Rihab Bouabsa; Mohamed Manai; Daniel Birnbaum; François Bertucci; Lamia Charfi; Maha Driss
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.